Literature DB >> 24688762

Spectrum of viral infections in patients with cystic fibrosis.

H Frickmann, S Jungblut, T O Hirche, U Groß, M Kuhns, A E Zautner.   

Abstract

This review explores the extensive influence of viral infections leading to chronic deterioration of lung function in patients with cystic fibrosis (CF). The mechanisms how viral agents affect the pathogenesis as well as the inflammatory and immune response of CF are discussed. Viral infections of the upper and lower respiratory tract due to viruses in CF patients and methods for diagnosis of respiratory viruses are described in detail. The importance of respiratory and non-respiratory viral agents for the pathogenesis, especially for the exacerbation of bacterial lower respiratory tract infections and course of CF, is stressed, especially emphasizing respiratory syncytial virus, influenza virus, rhinovirus, and human herpes viruses. Possible harmful effects of further viruses like adenovirus, bocavirus, coronavirus, metapneumovirus, parainfluenzavirus on the lung function of CF patients are discussed. The potential use of adenovirus-based vectors for somatic gene therapy is mentioned.

Entities:  

Keywords:  cystic fibrosis; human rhinovirus; immune response; infection; inflammation; mucoviscidosis; respiratory syncytial virus; virus

Year:  2012        PMID: 24688762      PMCID: PMC3962751          DOI: 10.1556/EuJMI.2.2012.3.1

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  98 in total

Review 1.  Diagnostic tests for influenza infection.

Authors:  Marie Louise Landry
Journal:  Curr Opin Pediatr       Date:  2011-02       Impact factor: 2.856

2.  Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells.

Authors:  A A Stecenko; G King; K Torii; R M Breyer; R Dworski; T S Blackwell; J W Christman; K L Brigham
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

Review 3.  Respiratory syncytial virus disease: update on treatment and prevention.

Authors:  Leonard R Krilov
Journal:  Expert Rev Anti Infect Ther       Date:  2011-01       Impact factor: 5.091

4.  Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients.

Authors:  F Watzinger; M Suda; S Preuner; R Baumgartinger; K Ebner; L Baskova; H G M Niesters; A Lawitschka; T Lion
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Ten years of viral and non-bacterial serology in adults with cystic fibrosis.

Authors:  I J Clifton; J A Kastelik; D G Peckham; A Hale; M Denton; C Etherington; S P Conway
Journal:  Epidemiol Infect       Date:  2007-03-12       Impact factor: 2.451

6.  Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer.

Authors:  J Rosenecker; K H Harms; R M Bertele; A Pohl-Koppe; E v Mutius; D Adam; T Nicolai
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

7.  Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis.

Authors:  A R Smyth; R L Smyth; C Y Tong; C A Hart; D P Heaf
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

8.  Is there a role for influenza vaccination in cystic fibrosis?

Authors:  Dennis Wat; Colin Gelder; Sam Hibbitts; Ian Bowler; Marcus Pierrepoint; Rachel Evans; Iolo Doull
Journal:  J Cyst Fibros       Date:  2007-07-05       Impact factor: 5.482

9.  Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis.

Authors:  Karin Giebels; Jacques-Edouard Marcotte; John Podoba; Céline Rousseau; Marie-Hélène Denis; Véronique Fauvel; Sophie Laberge
Journal:  Pediatr Pulmonol       Date:  2008-02

Review 10.  Viral respiratory infections in cystic fibrosis.

Authors:  Bart E van Ewijk; Marieke M van der Zalm; Tom F W Wolfs; Cornelis K van der Ent
Journal:  J Cyst Fibros       Date:  2005-08       Impact factor: 5.482

View more
  8 in total

1.  Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.

Authors:  Jason E Lang; Janet T Holbrook; Edward B Mougey; Christine Y Wei; Robert A Wise; W Gerald Teague; John J Lima
Journal:  Ann Am Thorac Soc       Date:  2015-06

Review 2.  Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat.

Authors:  Laura M Filkins; George A O'Toole
Journal:  PLoS Pathog       Date:  2015-12-31       Impact factor: 6.823

3.  Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity.

Authors:  Michael S D Kormann; Alexander Dewerth; Felizitas Eichner; Praveen Baskaran; Andreas Hector; Nicolas Regamey; Dominik Hartl; Rupert Handgretinger; Justin S Antony
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

Review 4.  More Pathogenicity or Just More Pathogens?-On the Interpretation Problem of Multiple Pathogen Detections with Diagnostic Multiplex Assays.

Authors:  Andreas E Zautner; Uwe Groß; Matthias F Emele; Ralf M Hagen; Hagen Frickmann
Journal:  Front Microbiol       Date:  2017-06-29       Impact factor: 5.640

5.  Viral respiratory tract infections in young children with cystic fibrosis: a prospective full-year seasonal study.

Authors:  Mathilde Eymery; Florence Morfin; Anne Doleans-Jordheim; Marie Perceval; Camille Ohlmann; Catherine Mainguy; Philippe Reix
Journal:  Virol J       Date:  2019-09-03       Impact factor: 4.099

Review 6.  Leveraging 3D Model Systems to Understand Viral Interactions with the Respiratory Mucosa.

Authors:  Ethan Iverson; Logan Kaler; Eva L Agostino; Daniel Song; Gregg A Duncan; Margaret A Scull
Journal:  Viruses       Date:  2020-12-11       Impact factor: 5.048

7.  Cystic Fibrosis: Systems Biology Analysis from Homozygous p.Phe508del Variant Patients' Samples Reveals Perturbations in Tissue-Specific Pathways.

Authors:  Joice de Faria Poloni; Thaiane Rispoli; Maria Lucia Rossetti; Cristiano Trindade; José Eduardo Vargas
Journal:  Biomed Res Int       Date:  2021-12-02       Impact factor: 3.411

8.  Adenovirus entry from the apical surface of polarized epithelia is facilitated by the host innate immune response.

Authors:  Poornima L N Kotha; Priyanka Sharma; Abimbola O Kolawole; Ran Yan; Mahmoud S Alghamri; Trisha L Brockman; Julian Gomez-Cambronero; Katherine J D A Excoffon
Journal:  PLoS Pathog       Date:  2015-03-13       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.